Rocket Pharmaceuticals, Inc. (RCKT) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$836
Total Return
-91.64%
CAGR
-39.13%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -1.97% |
| Median | -3.42% |
| Best | +70.41% |
| Worst | -67.77% |
| % of Windows Positive | 42.5% |
1-Year (252 Trading Days)
| Average | -21.61% |
| Median | -30.64% |
| Best | +170.77% |
| Worst | -89.73% |
| % of Windows Positive | 38.6% |
3-Year (756 Trading Days)
| Average | -60.47% |
| Median | -53.32% |
| Best | -14.80% |
| Worst | -85.98% |
| % of Windows Positive | 0.0% |
Risk Metrics
| Maximum Drawdown | -95.24% |
| Average Drawdown | -63.16% |
| Drawdown Duration | 1185 Trading Days (Unrecovered) |
| Sortino Ratio | -0.29 |
| Calmar Ratio | -0.41 |
| CVaR (5%) | -10.31% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +3.70% (+13.62% ann.) | +$370.39 | $0.00 | $0.00 | $0.00 |
| 2025 | -72.08% | $7207.64 | $0.00 | $0.00 | $0.00 |
| 2024 | -58.06% | $5805.81 | $0.00 | $0.00 | $0.00 |
| 2023 | +53.14% | +$5314.25 | $0.00 | $0.00 | $0.00 |
| 2022 | -10.35% | $1035.27 | $0.00 | $0.00 | $0.00 |
| 2021 | -60.19% | $6019.33 | $0.00 | $0.00 | $0.00 |
| 2020 | +140.95% | +$14094.91 | $0.00 | $0.00 | $0.00 |
| 2019 | +53.58% | +$5357.62 | $0.00 | $0.00 | $0.00 |
| 2018 | +41.95% | +$4195.40 | $0.00 | $0.00 | $0.00 |
| 2017 | -57.21% | $5721.31 | $0.00 | $0.00 | $0.00 |
| 2016 | -46.16% | $4616.06 | $0.00 | $0.00 | $0.00 |
| 2015 partial | +88.83% (+108.50% ann.) | +$8883.33 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | February 18, 2015 – February 19, 2020 | +0.04% | +0.01% | +$4.17 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -43.04% | -99.84% | $4303.74 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +109.51% | +228.71% | +$10950.65 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -19.90% | -18.98% | $1989.81 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -34.51% | -36.20% | $3450.67 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +20.98% | +10.82% | +$2097.67 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | -82.53% | -67.12% | $8253.35 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.